ASTROTECH Corp Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit
ASTROTECH Corp (ASTC) reported Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit of $175.50 per share for the 9-month period ending 2026-03-31, per its 10-Q/A filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit · last filed 2026-08-06
- ASTROTECH Corp share-based payment arrangement, option, exercise price range, upper range limit for the quarter ending 2024-09-30 was $175.50, a 0.00% change year-over-year.
- ASTROTECH Corp share-based payment arrangement, option, exercise price range, upper range limit for the quarter ending 2023-09-30 was $175.50, a 2900.00% increase year-over-year.
- ASTROTECH Corp share-based payment arrangement, option, exercise price range, upper range limit for the quarter ending 2022-09-30 was $5.85, a 2.50% decline year-over-year.
- ASTROTECH Corp share-based payment arrangement, option, exercise price range, upper range limit for the quarter ending 2022-03-31 was $6.00.
- ASTROTECH Corp share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2025 was $175.50, a 0.00% change from fiscal 2024.
- ASTROTECH Corp share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2024 was $175.50, a 0.00% change from fiscal 2023.
- ASTROTECH Corp share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2023 was $175.50, a 0.00% change from fiscal 2022.
- ASTROTECH Corp share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2022 was $175.50, a 2240.00% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 3 month | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 6 month | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 9 month | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 12 month | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $175.50 10-Q/A · filed 2026-08-06 | ||||
| 2025-12-31 | $175.50 10-Q · filed 2026-02-13 | ||||
| 2025-06-30 | $175.50 10-K · filed 2025-09-26 | ||||
| 2025-03-31 | $175.50 10-Q · filed 2025-05-14 | ||||
| 2024-12-31 | $175.50 10-Q · filed 2025-02-14 | ||||
| 2024-09-30 | $175.50 10-Q · filed 2024-11-13 | ||||
| 2024-06-30 | $175.50 10-K · filed 2025-09-26 | ||||
| 2024-03-31 | $175.50 10-Q · filed 2024-05-14 | ||||
| 2023-12-31 | $175.50 10-Q · filed 2024-02-13 | ||||
| 2023-09-30 | $175.50 10-Q · filed 2023-11-13 | ||||
| 2023-06-30 | $175.50 10-K · filed 2024-09-20 | ||||
| 2023-03-31 | $175.50 10-Q · filed 2023-05-12 | ||||
| 2022-12-31 | $175.50 10-Q · filed 2023-02-13 | ||||
| 2022-09-30 | $5.85 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | $175.50 10-K · filed 2023-09-28 | $6.00 10-K · filed 2022-09-15 | |||
| 2022-03-31 | $6.00 10-Q · filed 2022-05-13 | ||||
| 2021-12-31 | $6.00 10-Q · filed 2022-02-14 | ||||
| 2021-09-30 | $6.00 10-Q · filed 2021-11-12 | ||||
| 2021-06-30 | $7.50 10-K · filed 2022-09-15 | ||||
| 2021-03-31 | $8.35 10-Q · filed 2021-05-14 | ||||
| 2020-12-31 | $8.35 10-Q · filed 2021-02-16 | ||||
| 2020-09-30 | $8.35 10-Q · filed 2020-11-13 | ||||
| 2020-06-30 | $8.35 10-K · filed 2021-09-21 | ||||
| 2020-03-31 | $8.35 10-Q · filed 2020-05-14 | ||||
| 2019-12-31 | $8.35 10-Q · filed 2020-02-14 | ||||
| 2019-09-30 | $8.35 10-Q · filed 2019-11-14 | ||||
| 2019-06-30 | $8.35 10-K · filed 2020-09-08 | ||||
| 2019-03-31 | $8.35 10-Q · filed 2019-05-13 | ||||
| 2018-12-31 | $8.35 10-Q · filed 2019-02-12 | ||||
| 2018-09-30 | $8.35 10-Q · filed 2018-11-14 | ||||
| 2018-06-30 | $16.00 10-K · filed 2019-09-30 | ||||
| 2018-03-31 | $16.00 10-Q · filed 2018-05-15 | ||||
| 2017-12-31 | $16.00 10-Q · filed 2018-02-12 | ||||
| 2017-09-30 | $16.00 10-Q/A · filed 2018-02-12 | ||||
| 2017-06-30 | $16.00 10-K · filed 2018-09-25 | $3.20 10-K · filed 2017-09-18 | |||
| 2017-03-31 | $3.20 10-Q · filed 2017-05-09 | ||||
| 2016-12-31 | $3.20 10-Q · filed 2017-02-13 | ||||
| 2016-09-30 | $3.20 10-Q · filed 2016-11-14 | ||||
| 2016-06-30 | $3.20 10-K · filed 2017-09-18 | ||||
| 2016-03-31 | $3.20 10-Q · filed 2016-05-11 | ||||
| 2015-12-31 | $3.20 10-Q · filed 2016-02-10 | ||||
| 2015-09-30 | $3.20 10-Q · filed 2015-11-12 | ||||
| 2015-06-30 | $3.20 10-K · filed 2016-09-29 | ||||
| 2015-03-31 | $2.60 10-Q · filed 2015-05-11 | ||||
| 2014-12-31 | $2.60 10-Q · filed 2015-02-17 | $2.60 10-Q · filed 2015-02-17 | |||
| 2014-09-30 | $14.30 10-Q · filed 2014-11-14 | ||||
| 2014-06-30 | $24.10 10-K · filed 2015-09-22 | ||||
| 2013-12-31 | $24.10 10-Q · filed 2014-02-14 | $24.10 10-Q · filed 2014-02-14 | |||
| 2013-09-30 | $24.10 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | $24.10 10-K · filed 2014-09-30 | ||||
| 2013-03-31 | $24.10 10-Q · filed 2013-05-15 | ||||
| 2012-12-31 | $24.10 10-Q · filed 2014-02-14 | $24.10 10-Q · filed 2014-02-14 | |||
| 2012-09-30 | $24.10 10-Q · filed 2013-11-14 | ||||
| 2012-06-30 | $24.10 10-K · filed 2013-10-15 | ||||
| 2012-03-31 | $24.10 10-Q · filed 2013-05-15 | ||||
| 2011-12-31 | $24.10 10-Q · filed 2013-02-14 | $24.10 10-Q · filed 2013-02-14 | |||
| 2011-09-30 | $24.10 10-Q · filed 2012-11-14 | ||||
| 2011-06-30 | $26.00 10-K · filed 2012-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |